Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1996
08/20/1996US5547963 Method for stimulating nerve regeneration
08/20/1996US5547671 Extracts from kudzu plant, ginseng, ginger, citrus fruits, tree barks, thiamine
08/15/1996WO1996024596A1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
08/15/1996WO1996024595A1 New forms of paroxetin hydrochloride
08/15/1996WO1996024594A1 Benzoxazepine derivatives, salts thereof, and drugs containing the same
08/15/1996WO1996024588A1 Bicyclic isothiourea derivatives useful in therapy
08/15/1996WO1996024363A1 Therapeutic methods and preparations using rubidium ions
08/15/1996WO1996024350A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
08/15/1996WO1996024349A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases
08/15/1996WO1996018738A3 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1996011685A3 Use of indole derivatives for the treatment of various diseases
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/15/1996CA2211299A1 Bicyclic isothiourea derivatives useful in therapy
08/15/1996CA2187460A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases
08/14/1996EP0726265A1 10-Aminoaliphatyl-dibenz(b,f)oxepins with antineurodegenarative activity
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725779A1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
08/14/1996EP0725775A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
08/14/1996EP0725640A1 Use of lobeline for the treatment of nicotine withdrawal
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0670826A4 Fatty acid derivatives and pharmaceutical compositions containing them.
08/14/1996EP0660823B1 N-cyano-n'-pyridylguanidines as serotonin antagonists
08/14/1996EP0618913B1 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
08/14/1996DE19603797A1 Neue Formen von Paroxetin-Hydrochlorid New forms of paroxetine hydrochloride
08/14/1996CN1128999A Heterocyclic compounds
08/14/1996CN1128996A Substituted arylthioalkylthiopyridines
08/14/1996CN1128992A Therapeutic agents
08/14/1996CN1128991A N-substituted azaheterocyclic carboxylic acid and esters thereof
08/14/1996CN1128990A N-substituted azaheterocyclic carboxylic acid and esters thereof
08/14/1996CN1128989A N-substituted azaheterocylic carboxylic acid and esters thereof
08/14/1996CN1128988A N-substituted azaheterocyclic carboxylic acid and esters thereof
08/14/1996CN1128950A Method for modulating human sexual response
08/14/1996CN1128763A Quinolyl-one derivatives, prepn. method and application and use as medicine
08/14/1996CN1128762A Benzyl piperidine derivatives
08/14/1996CN1128757A 1,4-dihydro pyridine-3,5-dicarboxylic ester
08/14/1996CN1128756A Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatves as selective human NK3-receptor antagonists
08/14/1996CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof
08/14/1996CN1032533C Tramadol N-oxide material enantiomers and compositions thereof
08/13/1996US5545741 Epimerization in presence of base
08/13/1996US5545740 Nitrosation process
08/13/1996US5545656 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
08/13/1996US5545648 Use of 4-aminopyridine in the reduction of chronic pain and spasticity in a spinal cord injured patient
08/13/1996US5545645 Heterocyclic derivatives in the treatment of ischaemia and related diseases
08/13/1996US5545643 Useful for treating diseases of central nervous system
08/13/1996US5545631 N-substituted aminoalkanephosphinic acid derivatives, compositions thereof, and their use as anti-epileptics
08/13/1996US5545549 DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
08/13/1996CA2008107C 3- or 4-substituted oxotremorine derivatives
08/10/1996CA2169112A1 1-¬2-(substituted vinyl)|-3,4-dihydro-5h-2,3-benzodiazepine derivatives
08/08/1996WO1996024061A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023785A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
08/08/1996WO1996023784A1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/08/1996WO1996023783A1 Indole derivatives as 5-ht receptor antagonist
08/08/1996WO1996023769A2 Heterocyclic compounds possessing 5ht2c receptor antagonist activity
08/08/1996WO1996023760A1 2-aminoindans as selective dopamine d3 ligands
08/08/1996WO1996023522A1 Treatment of diabetic neuropathy
08/08/1996WO1996023496A1 Use of melatonin for treating patients suffering from drug addiction
08/08/1996WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9
08/08/1996WO1996015798A3 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
08/08/1996WO1996015244A3 Sensory and motor neuron derived factor (smdf)
08/08/1996CA2212061A1 Indole derivatives as 5-ht receptor antagonist
08/08/1996CA2211450A1 Treatment of diabetic neuropathy
08/08/1996CA2211189A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
08/08/1996CA2208600A1 2-aminoindans as selective dopamine d3 ligands
08/08/1996CA2186943A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/07/1996EP0725075A1 Peptide derivatives comprising a phosphinic acid moiety as inhibitors of zinc depending endopeptidase 24-25
08/07/1996EP0724637A1 Corticotropin-releasing factor 2 receptors
08/07/1996EP0724632A1 Stem cell proliferation factor
08/07/1996EP0724589A1 A method for enhancing neurone survival and agents useful for same
08/07/1996EP0724584A1 Heterocyclic amines having central nervous system activity
08/07/1996EP0724583A1 Pyridazino quinoline compounds
08/07/1996EP0724580A1 Benzanilide derivatives as 5ht-1d receptor antagonists
08/07/1996EP0724578A1 Amine derivatives as calcium channel antagonists
08/07/1996EP0724577A1 Heterocyclic amines for treating ischaemic strokes
08/07/1996EP0724572A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
08/07/1996EP0724439A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents
08/07/1996EP0583280B1 Use of torasemide for the treatment of cerebral oedema
08/07/1996CN1128264A Crystalline form of dihydro-2,3-benzodiazepine derivative
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/07/1996CN1128260A New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them
08/07/1996CN1128259A A process for preparing substituted methane-sulphonamide sulphate and solvates thereof
08/07/1996CN1128142A Gepirone dosage form
08/07/1996CN1128141A Duloxetine enteric pellets
08/06/1996US5543556 Esters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma
08/06/1996US5543530 4-arylisoindole analgesics
08/06/1996US5543528 Useful as angiotensin ii antagonist
08/06/1996US5543434 Nasal administration of ketamine to manage pain
08/06/1996US5543426 Use of certain 3,7-disubstituted indole compounds for treating depression or cognitive disorders
08/06/1996US5543421 Method of treatment of peripheral neuropathies and central neurodegenerative diseases
08/06/1996US5543420 Aldose reductase inhibitors; antidiabetic agents; prevention of accumulation of sorbitol and galactitol in mammalian tissue
08/06/1996US5543419 Treating chronic obstructive airways disease or asthma; antimuscarinic bronchodilator agents
08/06/1996CA1338508C Method and compositions for treatment of parkinsonism syndrome in mammals
08/01/1996WO1996023000A1 Ligands for eph-like receptors
08/01/1996WO1996022991A1 Bicyclic substituted hexahydrobenz[e]isoindole alpha-1- adrenergic antagonists
08/01/1996WO1996022990A2 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
08/01/1996WO1996022978A1 Substituted phenyl compounds as endothelin antagonists
08/01/1996WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof
08/01/1996WO1996022774A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
08/01/1996WO1996022772A1 Method for treating multiple sclerosis
1 ... 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 ... 1833